Xcout IntelParabilis Medicines, Inc.
Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them. The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.
Subscribe to see Parabilis Medicines, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Parabilis Medicines, Inc. at a glance
Parabilis Medicines, Inc. is a pharmaceuticals company headquartered in Cambridge, United States. It is publicly listed (PBLS) with a market capitalisation of $3.2B. Xcout tracks 20 named people at Parabilis Medicines, Inc., including Mathai Mammen (CEO, President, Treasurer & Chairman). Xcout recorded 31 job postings from Parabilis Medicines, Inc. in the last 90 days, naming tools such as Claude Code, Okta.
Parabilis Medicines, Inc. leadership
- Mathai MammenCEO, President, Treasurer & Chairman
- Thomas Rodolpho KotarakosChief Financial Officer
- Mohammed Fawzi BenzaghouChief Medical Officer
- Huei-inChief Business & Strategy Officer
- Kristen StantsChief People Officer
- Rohin MhatreChief Technical Operations Officer
14 more named people on record for Parabilis Medicines, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Parabilis Medicines, Inc.
Xcout recorded 31 job postings from Parabilis Medicines, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
Tools named in Parabilis Medicines, Inc.'s job postings
The weekly hiring trend, the roles and locations behind it — see Parabilis Medicines, Inc.'s hiring signals →
Recent Parabilis Medicines, Inc. news
- IPOParabilis Medicines, Inc. IPO on NASDAQ
- IPOIPO registration (S-1)
- IPOIPO registration (S-1)
- IPOIPO registration (S-1)
6 corporate events on record, with sources — see the full timeline →
Tech stack
Parabilis Medicines, Inc. competitors
A few of Parabilis Medicines, Inc.'s closest competitors — see the full list of competitors and alternatives →
Danqing Pharmaceuticals is a pharmaceutical company headquartered in Beijing with a U.S. subsidiary in Boston. The company focuses on first-in-class drug discovery and development in oncology, targeting therapeutic areas such as breast, gynecological, and gastrointestinal cancers.
Cao Pharmaceuticals Inc. develops anti-cancer drugs utilizing natural anti-cancer compounds. The company focuses on research, product pipelines, and developing lead drug candidates for cancer treatment.
Shanghai CureGene Pharmaceutical Co., Ltd. is a biopharmaceutical company founded in Zhangjiang, Shanghai, in 2018. It specializes in developing state-of-the-art medications and has built a globally leading targeted prodrug platform.
Arisaph Pharmaceuticals Inc. is a Boston, Massachusetts-based biopharmaceutical company that utilizes drug discovery platforms to develop novel therapies for cancer, cardiovascular disease, and diabetes. The company's pipeline includes small molecule inhibitors and differentiated medicines aimed at cardiometabolic diseases and oncology.
Novilla Pharmaceuticals is a biotechnology company headquartered in Cambridge, Massachusetts, developing a novel class of localized medicines designed by AI to treat pain. The firm focuses on targeted therapeutics that function only where needed within the body. It operates as a privately held startup with a small scientific team.
Foghorn Therapeutics is a biopharmaceutical company headquartered in Watertown, Massachusetts. The company is pioneering a new class of medicines that treat serious diseases by leveraging insights into the chromatin regulatory system.
Get Parabilis Medicines, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Parabilis Medicines, Inc. in Xcout Intel
- 20 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- 6 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access